Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM
The Vanguard Group reported a 9.30% stake in Rhythm Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 9.30% stake in Rhythm Pharmaceuticals, Inc., 6,210,916 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 9.30%
- Shares
- 6,210,916
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 9.30% | 6,210,916 |
Source
Related
- Rhythm Pharmaceuticals, Inc.
- The Vanguard Group
- Rhythm Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · The Vanguard Group · Oct 30, 2025
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Meeker David P · Sep 14, 2026
- Form 4 · Smith Hunter C · Sep 1, 2026
- Form 4 · Shulman Joseph · Aug 17, 2026
- Form 4 · Garfield Alastair · Aug 17, 2026